Viva Biotech (Shanghai) Ltd.

Established in 2008, Zhangjiang, Shanghai, Viva Biotech (Shanghai) Ltd. is a leading open-access and innovation-driven technology platform company which is dedicated to pre-clinic drug discovery.

EFS

Antibody

Viva is devoted to pushing the boundary of GPCR protein studies. Working closely with experienced experts from GPCR field, well trained researchers in Viva Biotech are able to deliver top quality Cry

【Update Notice】Invitation Letter for Viva Biotech 2020 Online Investor Day

Viva Biotech 2020 Investor Day is rescheduled to December 8.

Xlement Attended 3rd China International Import Exhibition

Bringing NanoSPR handheld detector and SARS-CoV-2 virus particle antigen detection kit to join the CIIE.

Arthrosi Therapeutics Released Phase 2 Clinical Data of AR882

AR882 demonstrated a strong safety profile, favorable pharmacokinetics, pharmacodynamics, and efficacy outcome.

Viva Biotech Enters Strategic Collaboration with Biocytogen to Accelerate Early-stage Drug Discovery

The collaboration will combine Biocytogen’s fully human antibody mouse platforms with Viva Biotech’s structure-based, integrated drug discovery platform, to achieve synergies